# Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

> **NCT01494363** · PHASE2 · UNKNOWN · sponsor: **Soon Chun Hyang University** · enrollment: 53 (estimated)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** Fluorouracil
- **DRUG:** Leucovorin
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT01494363
- **Lead sponsor:** Soon Chun Hyang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2011-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494363, "Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01494363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*